Skip Ribbon Commands
Skip to main content
Sign In

26117 Anaplasma phagocytophilum (Human Granulocytic Ehrlichiosis) Antibody, Serum (ANAP)

Anaplasma phagocytophilum (Human Granulocytic Ehrlichiosis) Antibody, Serum (ANAP)
Test Code: ANAPSO
Synonyms/Keywords

​Ehrlichiosis Serology
Human Granulocytic Anaplasmosis (HGA)
Human Granulocytic Ehrlichiosis (HGE)
Anaplasma phagocytophilum

Anaplasma phagocytophilum Ab, IgG, S (ANAP)

Useful For

As an adjunct in the diagnosis of human granulocytic ehrlichiosis

Seroepidemiological surveys of the prevalence of the infection in certain populations

Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Serum ​Serum Separator Tube (SST) ​Red Top Tube (RTT) ​0.5 mL​0.4 mL
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​Refrigerate (preferred) ​14 days
​Frozen ​14 days
Rejection Criteria
Gross Hemolysis
​Gross Lipemia
​Gross Icterus
​Heat-inactivated specimen
Interference

​Previous episodes of human granulocytic ehrlichiosis may produce a positive serologic result.

In rare instances, clinical evidence of infection may also be derived by direct microscopic examination of Giemsa- or Diff-Quik-stained peripheral blood buffy coat smears, which may reveal clusters of round, dark-purple stained, small dots or clusters of dots (morulae) in the cytoplasm of polymorphonuclear cells. However, this is a very insensitive method.

Performance characteristics have not been established for hemolyzed or lipemic specimens.

Performing Laboratory Information
Performing Location Day(s) Test Performed Report Available Methodology/Instrumentation
​Mayo Clinic Laboratories ​Monday through Friday ​1 to 3 days ​Immunofluorescence Assay (IFA)
Reference Lab
Test Information

Anaplasma phagocytophilum, an intracellular rickettsia-like bacterium, preferentially infects granulocytes and forms inclusion bodies, referred to as morulae. A phagocytophilum is transmitted by Ixodes species ticks, which also transmit Borrelia burgdorferi and Babesia species. Infection with A phagocytophilum is also referred to as human granulocytic anaplasmosis (HGA) and symptoms in otherwise healthy individuals are often mild and nonspecific, including fever, myalgia, arthralgia, and nausea. Clues to the diagnosis of anaplasmosis in a patient with an acute febrile illness after tick exposure include laboratory findings of leukopenia or thrombocytopenia and elevated liver enzymes. HGA is most prevalent in the upper Midwest and in other areas of the United States that are endemic for Lyme disease.

Reference Range Information
Performing Location Reference Range
​Mayo Clinic Laboratories

​<1:64

Reference values apply to all ages.

Interpretation

A positive result of an immunofluorescence assay (IFA) test (titer > or =1:64) suggests current or previous infection with human granulocytic ehrlichiosis. In general, the higher the titer, the more likely it is that the patient has an active infection.

Seroconversion may also be demonstrated by a significant increase in IFA titers.

During the acute phase of the infection, serologic tests are often nonreactive, polymerase chain reaction (PCR) testing is available to aid in the diagnosis of these cases (see EHRL / Ehrlichia/Anaplasma, Molecular Detection, PCR, Blood).

Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​86666 ​1
Synonyms/Keywords

​Ehrlichiosis Serology
Human Granulocytic Anaplasmosis (HGA)
Human Granulocytic Ehrlichiosis (HGE)
Anaplasma phagocytophilum

Anaplasma phagocytophilum Ab, IgG, S (ANAP)

Ordering Applications
Ordering Application Description
​COM​Anaplasma phagocytophilum Ab, IgG, S (ANAP)
​Cerner ​Anaplasma phagocytophilum Ab, IgG, S (ANAP)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Serum ​Serum Separator Tube (SST) ​Red Top Tube (RTT) ​0.5 mL​0.4 mL
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​Refrigerate (preferred) ​14 days
​Frozen ​14 days
Rejection Criteria
Gross Hemolysis
​Gross Lipemia
​Gross Icterus
​Heat-inactivated specimen
Interference

​Previous episodes of human granulocytic ehrlichiosis may produce a positive serologic result.

In rare instances, clinical evidence of infection may also be derived by direct microscopic examination of Giemsa- or Diff-Quik-stained peripheral blood buffy coat smears, which may reveal clusters of round, dark-purple stained, small dots or clusters of dots (morulae) in the cytoplasm of polymorphonuclear cells. However, this is a very insensitive method.

Performance characteristics have not been established for hemolyzed or lipemic specimens.

Useful For

As an adjunct in the diagnosis of human granulocytic ehrlichiosis

Seroepidemiological surveys of the prevalence of the infection in certain populations

Reference Range Information
Performing Location Reference Range
​Mayo Clinic Laboratories

​<1:64

Reference values apply to all ages.

Interpretation

A positive result of an immunofluorescence assay (IFA) test (titer > or =1:64) suggests current or previous infection with human granulocytic ehrlichiosis. In general, the higher the titer, the more likely it is that the patient has an active infection.

Seroconversion may also be demonstrated by a significant increase in IFA titers.

During the acute phase of the infection, serologic tests are often nonreactive, polymerase chain reaction (PCR) testing is available to aid in the diagnosis of these cases (see EHRL / Ehrlichia/Anaplasma, Molecular Detection, PCR, Blood).

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Report Available Methodology/Instrumentation
​Mayo Clinic Laboratories ​Monday through Friday ​1 to 3 days ​Immunofluorescence Assay (IFA)
Reference Lab
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
​86666 ​1
For most current information refer to the Marshfield Laboratory online reference manual.